EMPRESS LABORATORIES LTD
Executive Summary
Empress Laboratories Ltd operates as a financially stable niche provider within the UK’s professional scientific and technical activities sector, exhibiting modest scale but positive working capital and equity growth. The company benefits from its agility and focused service offering amid sector trends emphasizing specialization and regulatory compliance, though it faces competitive pressures from larger, resource-rich peers. Strategic emphasis on leveraging specialized expertise and maintaining financial prudence will be key to sustaining its market position.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 01/04/251 April 2025 | Total exemption full accounts made up to 2024-11-30 |
| 05/12/245 December 2024 | Confirmation statement made on 2024-11-24 with no updates |
| 30/11/2430 November 2024 | Annual accounts for year ending 30 Nov 2024 |
| 20/02/2420 February 2024 | Total exemption full accounts made up to 2023-11-30 |
| 30/11/2330 November 2023 | Annual accounts for year ending 30 Nov 2023 |
| 24/11/2324 November 2023 | Confirmation statement made on 2023-11-24 with no updates |
| 31/05/2331 May 2023 | Total exemption full accounts made up to 2022-11-30 |
| 29/11/2229 November 2022 | Confirmation statement made on 2022-11-24 with no updates |
| 28/03/2228 March 2022 | Total exemption full accounts made up to 2021-11-30 |
| 07/12/217 December 2021 | Confirmation statement made on 2021-11-24 with no updates |
| 30/11/2130 November 2021 | Annual accounts for year ending 30 Nov 2021 |
| 25/11/2025 November 2020 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company